PTC Therapeutics Shares Dip ~$0.17 Over Last Min as Traders Circulating Press Release from Oversight & Gov't Reform 'Sanders and Cummings Request Pricing Info From PTC Therapeutics for Critical Drug'
Paul Quintaro